Current Filters

Showing 1 - 10 results of 2969

Mirabegron (Myrbetriq) (Last Updated: Nov 27, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Myrbetriq
Manufacturer:
Astellas Pharma Canada Inc.
Submission Type:
Initial
Indications:

Bladder, overactive

Aclidinium bromide (Tudorza Genuair) (Last Updated: Aug 21, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Tudorza Genuair
Manufacturer:
Almirall Canada Ltd.
Submission Type:
Initial
Indications:

Chronic Obstructive Pulmonary Disease (COPD)

OnabotulinumtoxinA (Botox) (Last Updated: Aug 15, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Botox
Manufacturer:
Allergan Inc.
Submission Type:
Initial
Indications:

Migraine, chronic

Riociguat (Adempas) (Last Updated: Sep 30, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Adempas
Manufacturer:
Bayer Inc.
Submission Type:
Initial
Indications:

Pulmonary hypertension, chronic thromboembolic

Tapentadol (Nucynta CR) (Last Updated: Feb 1, 2011)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Nucynta CR
Manufacturer:
Janssen Inc.
Submission Type:
Initial
Indications:

Pain, moderate to moderately severe

Sapropterin dihydrochloride (Kuvan) (Last Updated: Jul 8, 2010)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Kuvan
Manufacturer:
BioMarin Pharmaceutical Canada Inc.
Submission Type:
Initial
Indications:

Phenylketonuria (PKU).

Liraglutide (Victoza) (Last Updated: Nov 29, 2010)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Victoza
Manufacturer:
Novo Nordisk Canada Inc.
Submission Type:
Initial
Indications:

Diabetes mellitus, Type 2

COVID-19 Update (Last Updated: Feb 22, 2021)

CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time. Our COVID-19 Evidence Portal contains the latest COVID-19 information from CADTH and...
Project Line:
New at CADTH

COVID-19 Update (Last Updated: Feb 16, 2021)

CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time. Our COVID-19 Evidence Portal contains the latest COVID-19 information from CADTH and...
Project Line:
New at CADTH
Download results as CSV